DCK and cancer: A humanized yeast phenomic model of deoxycytidine kinase was developed to map drug–gene interactions modulating antiproliferative effects of nucleoside analogs in a eukaryotic cell and to investigate the relevance of the resulting networks for precision oncology by integration with cancer pharmacogenomics-derived associations between gene expression and cancer cell line drug sensitivity.